Ribometrix Presents First c-MYC Data Validating RNA-Targeting Platform and Demonstrates Synergistic Potential of eIF4E Program at AACR 2024
Ribometrix to Present New Data From RNA-Modulating Small Molecule Programs
Ribometrix Demonstrates Progress for eIF4E Program at Breast Cancer Symposium
Ribometrix to Present Additional Preclinical Data for eIF4E Program
Ribometrix Announces Lead Program Target and Presentation of Preclinical Data
Ribometrix, a biotechnology company developing small molecule therapeutics that directly target RNA to treat human diseases, announced today the appointment of Manjunath (Manju) Ramarao, Ph.D., as senior vice president (SVP) in its research and development (R&D) team.